Table 4: Effect of administration of Las01 on biochemical parameters of cancer patients.


Normal range Pretreatment1 year after treatment

LFT
 Serum bilirubin (T) 0.2–1.0 mg/dL 0.75 0.78
 Serum bilirubin (D) 0.0–0.3
mg/dL
0.32 0.34
 Bilirubin (ID) 0.1–1.0
mg/dL
0.43 0.44
 SGOT 0–37 (M) 0–31 (F) lu/L 31 28
 SGPT 0–37 (M) 0–31 (F) lu/L 29 30
 S-Alkaline phosphatase 100–275 lu/L 192 185

KFT
 Blood urea 15–50 mg% 22.6 22.7
 S. uric acid 2.0–6.0 mg% 3.9 3.82
 Creatinine 0.0–2.0 mg% 0.6 0.7
 RBS 70–150 mg% 75 80
 Total protein 6.0–9.0 mg% 7.2 7.1
 Albumin 3.0–6.0 gm% 3.2 3.0
 Globulin 2.0–5.0 gm% 4.0 4.1

Electrolyte
 Serum sodium 135–145 meq/L 140.2 141.1
 Serum potassium 3.0–6.0 meq/L 4.21 5.0